Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ACRX

AcelRx

$3.81

-0.065 (-1.68%)

, ATRS

Antares Pharma

$3.25

-0.1 (-2.99%)

08:32
10/02/18
10/02
08:32
10/02/18
08:32
Conference/Events
Ladenburg to hold a conference »

2018 Healthcare…

ACRX

AcelRx

$3.81

-0.065 (-1.68%)

ATRS

Antares Pharma

$3.25

-0.1 (-2.99%)

MNOV

MediciNova

$12.85

0.37 (2.96%)

CBIO

Catalyst Biosciences

$10.51

-0.26 (-2.41%)

LPCN

Lipocine

$1.38

-0.015 (-1.08%)

YTEN

Yield10 Bioscience

$1.45

0.03 (2.11%)

ONCY

Oncolytics

$4.02

0.14 (3.61%)

PTN

Palatin

$0.97

-0.02 (-2.02%)

VERU

Veru

$1.32

-0.11 (-7.69%)

MESO

Mesoblast

$8.63

0.47 (5.76%)

NTGN

Neon Therapeutics

$11.52

2.97 (34.74%)

EYEN

Eyenovia

$3.85

-0.15 (-3.75%)

RDHL

RedHill Biopharma

$8.92

0.09 (1.02%)

CYCC

Cyclacel Pharmaceuticals

$1.40

0.02 (1.45%)

DOVA

Dova Pharmaceuticals

$20.70

-0.23 (-1.10%)

LPTX

Leap Therapeutics

$7.94

0.09 (1.15%)

OVID

Ovid Therapeutics

$5.72

0.09 (1.60%)

CLLS

Cellectis

$27.92

-0.34 (-1.20%)

CURE

Curative Health Services Inc

$67.80

1.28 (1.92%)

OPGN

OpGen

$1.96

-0.04 (-2.00%)

TRIL

Trillium Therapeutics

$5.77

-0.18 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 03

    Oct

  • 12

    Oct

  • 03

    Nov

  • 13

    Nov

  • 27

    Nov

OVID

Ovid Therapeutics

$5.60

-0.35 (-5.88%)

, TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

08:36
09/24/18
09/24
08:36
09/24/18
08:36
Hot Stocks
Ovid Therapeutics, Takeda announce initiation of two Phase 2 trials »

Ovid Therapeutics (OVID)…

OVID

Ovid Therapeutics

$5.60

-0.35 (-5.88%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 27

    Nov

Over a month ago
INFI

Infinity Pharmaceuticals

$2.48

0.04 (1.64%)

, NTRP

Neurotrope

$9.40

0.39 (4.33%)

07:33
09/07/18
09/07
07:33
09/07/18
07:33
Conference/Events
BioCentury to hold a conference »

25th Annual NewsMakers in…

INFI

Infinity Pharmaceuticals

$2.48

0.04 (1.64%)

NTRP

Neurotrope

$9.40

0.39 (4.33%)

TNXP

Tonix Pharmaceuticals

$1.02

-0.02 (-1.92%)

ARCT

Arcturus Therapeutics

$7.91

-0.06 (-0.75%)

OVID

Ovid Therapeutics

$6.09

-0.23 (-3.64%)

OBSV

ObsEva

$13.57

0.02 (0.15%)

EIGR

Eiger BioPharmaceuticals

$12.50

-0.3 (-2.34%)

BSTC

BioSpecifics

$54.33

-0.21 (-0.39%)

TPIV

TapImmune

$9.18

-0.47 (-4.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

OVID

Ovid Therapeutics

$6.45

-0.23 (-3.44%)

16:10
09/04/18
09/04
16:10
09/04/18
16:10
Hot Stocks
Ovid Therapeutics CFO Yaron Werber leaving company »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 07

    Sep

OVID

Ovid Therapeutics

$6.46

-0.095 (-1.45%)

16:03
08/16/18
08/16
16:03
08/16/18
16:03
Hot Stocks
Ovid Therapeutics announces Phase 2 STARS topline data accepted for presentation »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$6.20

0.22 (3.68%)

12:55
08/10/18
08/10
12:55
08/10/18
12:55
Recommendations
Ovid Therapeutics analyst commentary at Piper Jaffray »

Piper sees value coming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$6.00

-0.04 (-0.66%)

16:05
08/09/18
08/09
16:05
08/09/18
16:05
Earnings
Ovid Therapeutics reports Q2 EPS (53c), consensus (60c) »

As of June 30, cash, cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$6.19

-3.36 (-35.18%)

15:12
08/06/18
08/06
15:12
08/06/18
15:12
Recommendations
Ovid Therapeutics analyst commentary at Piper Jaffray »

Ovid Therapeutics shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

OVID

Ovid Therapeutics

$9.55

-0.15 (-1.55%)

07:33
08/06/18
08/06
07:33
08/06/18
07:33
Conference/Events
Ovid Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

OVID

Ovid Therapeutics

$9.55

-0.15 (-1.55%)

07:30
08/06/18
08/06
07:30
08/06/18
07:30
Hot Stocks
Breaking Hot Stocks news story on Ovid Therapeutics »

Ovid Therapeutics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.